A randomized trial predicting response to cognitive rehabilitation in multiple sclerosis: Is there a window of opportunity?
Stefanos E Prouskas(Amsterdam UMC Location Vrije Universiteit Amsterdam), Hanneke E. Hulst(Amsterdam UMC Location Vrije Universiteit Amsterdam), Frederik Barkhof(Netherlands Institute for Neuroscience), Brigit A. de Jong(Amsterdam Neuroscience), Martijn D. Steenwijk(Amsterdam Neuroscience), Menno M. Schoonheim(Amsterdam Neuroscience), Marijn Huiskamp(Amsterdam Neuroscience), Karin Gehring(Tilburg University), Margriet M. Sitskoorn(University Medical Center Utrecht), Jeroen J.G. Geurts(Amsterdam Neuroscience)
Cited by 19
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k